These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23375312)

  • 1. Early allograft dysfunction is associated with excess resource utilization after liver transplantation.
    Croome KP; Hernandez-Alejandro R; Chandok N
    Transplant Proc; 2013; 45(1):259-64. PubMed ID: 23375312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs.
    Foxton MR; Al-Freah MA; Portal AJ; Sizer E; Bernal W; Auzinger G; Rela M; Wendon JA; Heaton ND; O'Grady JG; Heneghan MA
    Liver Transpl; 2010 May; 16(5):668-77. PubMed ID: 20440776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
    Wagener G; Raffel B; Young AT; Minhaz M; Emond J
    Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission.
    Buchanan P; Dzebisashvili N; Lentine KL; Axelrod DA; Schnitzler MA; Salvalaggio PR
    Liver Transpl; 2009 Oct; 15(10):1270-7. PubMed ID: 19790155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing liver transplant length of stay at two large-volume transplant centers.
    Washburn WK; Meo NA; Halff GA; Roberts JP; Feng S
    Liver Transpl; 2009 Nov; 15(11):1570-8. PubMed ID: 19877222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.
    Medici V; Rossaro L; Wegelin JA; Kamboj A; Nakai J; Fisher K; Meyers FJ
    Liver Transpl; 2008 Aug; 14(8):1100-6. PubMed ID: 18668666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HALOS-ND model: a step in the journey of predicting hospital length of stay after liver transplantation.
    Krishnan KR; Bhattacharya R; Pereira A; Otto AK; Carithers RL; Reyes JD; Perkins JD
    Clin Transplant; 2013; 27(6):809-22. PubMed ID: 23991828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic.
    Agopian VG; Kaldas FM; Hong JC; Whittaker M; Holt C; Rana A; Zarrinpar A; Petrowsky H; Farmer D; Yersiz H; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2012 Oct; 256(4):624-33. PubMed ID: 22964732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.
    Olthoff KM; Kulik L; Samstein B; Kaminski M; Abecassis M; Emond J; Shaked A; Christie JD
    Liver Transpl; 2010 Aug; 16(8):943-9. PubMed ID: 20677285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost prediction in liver transplantation using pretransplant donor and recipient characteristics.
    Earl TM; Cooil B; Rubin JE; Chari RS
    Transplantation; 2008 Jul; 86(2):238-44. PubMed ID: 18645485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era.
    Briceño J; Ciria R; de la Mata M; Rufián S; López-Cillero P
    Transplantation; 2010 Sep; 90(5):530-9. PubMed ID: 20581766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function.
    Cywinski JB; Mascha E; Miller C; Eghtesad B; Nakagawa S; Vincent JP; Pesa N; Na J; Fung JJ; Parker BM
    Liver Transpl; 2008 Jan; 14(1):59-65. PubMed ID: 18161840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term outcomes after steatotic liver transplantation.
    Doyle MB; Vachharajani N; Wellen JR; Anderson CD; Lowell JA; Shenoy S; Brunt EM; Chapman WC
    Arch Surg; 2010 Jul; 145(7):653-60. PubMed ID: 20644128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental costs of post-liver transplantation complications.
    Ammori JB; Pelletier SJ; Lynch R; Cohn J; Ads Y; Campbell DA; Englesbe MJ
    J Am Coll Surg; 2008 Jan; 206(1):89-95. PubMed ID: 18155573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live donor liver transplantation in high MELD score recipients.
    Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR
    Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.